Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)

Historical Holders from Q1 2024 to Q3 2025

Symbol
KYTX on Nasdaq
Type / Class
Equity / Common Stock, par value $0.00001 per share
Shares outstanding
43,692,643
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
22,688,863
Holdings value
$136,134,153
% of all portfolios
0%
Number of holders
74
Number of buys
27
Number of sells
-42
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
GordonMD Global Investments LP 7% $23,275,071 3,058,485 GordonMD Global Investments LP 13 Nov 2025

Institutional Holders of Kyverna Therapeutics, Inc. - Common Stock, par value $0.00001 per share (KYTX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 22,688,863 $136,134,153 -$2,158,017 $6 74
2025 Q2 23,200,134 $71,227,727 -$5,373,744 $3.07 77
2025 Q1 25,800,890 $49,797,231 -$8,775,592 $1.93 86
2024 Q4 28,863,400 $107,952,189 -$6,920,913 $3.74 87
2024 Q3 28,136,737 $138,294,516 -$28,965,516 $4.89 92
2024 Q2 31,935,411 $239,516,646 -$86,044,405 $7.5 87
2024 Q1 30,688,965 $762,283,849 +$760,773,578 $24.84 88